Effectiveness of first antiepileptic drug

Epilepsia

Volumn 42, Issue 10, 2001, Pages 1255-1260

  Kwan, Patrick ^a   Brodie, Martin J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Antiepileptic drugs; Effectiveness; Efficacy; Epilepsy; Tolerability

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; VALPROIC ACID;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; MALE; TREATMENT OUTCOME; TRIAZINES; VALPROIC ACID;

EID: 0035160282     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.04501.x     Document Type: Article

References (30)

1. Early identification of refractory epilepsy
2. VA Epilepsy Cooperative Study No. 264 Group: A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults
3. A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy
4. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
5. Monotherapy trials of new antiepileptic drugs
6. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy
7. Monotherapy clinical trials of new antiepileptic drugs: Design, indications, and controversies
8. Principles of drug treatment
9. Difficulties in extrapolating from clinical trial data to clinical practice: The case of antiepileptic drugs
10. Can randomised trials inform clinical decisions about individual patients?
11. Randomized trials or observational tribulations?
12. Topiramate in refractory epilepsy: A prospective observational study
13. An outcome audit at the epilepsy clinic: Results from 1000 consecutive referrals
14. Proposal for revised classification of epilepsies and epileptic syndromes
15. Guidelines for epidemiological studies on epilepsy
16. The star systems: Overview and use in determining antiepileptic drug choice
17. Management of epilepsy in adolescents and adults
18. Antiepileptic drugs
19. New antiepileptic drugs
20. Five years of anticonvulsant monitoring on site at the epilepsy clinic
21. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: A randomised comparative monotherapy trial
22. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy
23. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy
24. Valproate versus carbamazepine for seizures
25. Is the underlying cause of epilepsy a major prognostic factor for recurrence?
26. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?
27. Pharmacogenetics and future drug development and delivery
28. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures
29. Topiramate versus investigator choice of carbamazepine or valproate as monotherapy in newly diagnosed epilepsy
30. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalised tonic-clonic seizures